LUMOS PHARMA INC's ticker is LUMO and the CUSIP is 55028X109. A total of 47 filers reported holding LUMOS PHARMA INC in Q1 2020. The put-call ratio across all filers is 5.03 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $423 | -10.0% | 150 | 0.0% | 0.00% | – |
| Q4 2023 | $470 | -5.1% | 150 | 0.0% | 0.00% | – |
| Q3 2023 | $495 | 0.0% | 150 | 0.0% | 0.00% | – |
| Q2 2023 | $495 | -2.8% | 150 | 0.0% | 0.00% | – |
| Q1 2023 | $509 | -6.1% | 150 | 0.0% | 0.00% | – |
| Q4 2022 | $542 | -45.8% | 150 | 0.0% | 0.00% | – |
| Q3 2022 | $1,000 | 0.0% | 150 | 0.0% | 0.00% | – |
| Q2 2022 | $1,000 | 0.0% | 150 | 0.0% | 0.00% | – |
| Q1 2022 | $1,000 | 0.0% | 150 | 0.0% | 0.00% | – |
| Q4 2021 | $1,000 | 0.0% | 150 | 0.0% | 0.00% | – |
| Q3 2021 | $1,000 | 0.0% | 150 | 0.0% | 0.00% | – |
| Q2 2021 | $1,000 | -50.0% | 150 | 0.0% | 0.00% | – |
| Q1 2021 | $2,000 | -60.0% | 150 | 0.0% | 0.00% | – |
| Q4 2020 | $5,000 | -94.2% | 150 | -97.1% | 0.00% | – |
| Q2 2020 | $86,000 | +109.8% | 5,197 | +8.8% | 0.00% | – |
| Q1 2020 | $41,000 | – | 4,775 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lion Point Capital, LP | 407,192 | $14,540,000 | 2.80% |
| Opaleye Management Inc. | 281,287 | $10,045,000 | 1.31% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 936,291 | $33,435,000 | 0.66% |
| NEA Management Company, LLC | 526,663 | $18,807,000 | 0.50% |
| Investors Financial Group, LLC | 18,200 | $650,000 | 0.43% |
| One68 Global Capital, LLC | 5,855 | $209,000 | 0.42% |
| Wealth Advisors of Iowa, LLC | 11,760 | $420,000 | 0.26% |
| Blackstone Inc. | 468,145 | $16,717,000 | 0.06% |
| Foster Group, Inc. | 7,283 | $221,000 | 0.04% |
| Texas Yale Capital Corp. | 16,000 | $571,000 | 0.04% |